BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Special

BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future

The Asia-Pacific (APAC) region is rapidly emerging as a global powerhouse in the biopharmaceutical industry. This growth is fueled by a combination of inno...

December 20, 2024 | Analysis

25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility

Pioneering a Greener Future for Healthcare Innovation The biopharmaceutical industry is undergoing a transformative shift as environmental sustainability ...

December 17, 2024 | Report

India’s Biotech Boom: Supriya Kashikar on Startups, Innovation, and the Road to 2030

India’s biotechnology sector is on a trajectory to reach $300 billion by 2030, fueled by a dynamic startup ecosystem, robust government initiatives l...

December 17, 2024 | Interview

Driving Precision Medicine with AI: Tomasz Jetka, PhD, on Ardigen’s Vision for 2025

In an exclusive conversation with BioPharma APAC, Tomasz Jetka, PhD, Director of AI at Ardigen, delves into the company's ambitious plans to revolutionize ...

December 16, 2024 | Interview

Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness

In an exclusive interview with BioPharma APAC, Mr. Brendan O’Callaghan, Executive Vice President, Manufacturing & Supply at Sanofi, sheds light o...

December 09, 2024 | News

AstraZeneca's Drive to Transform Lung Cancer Care in LMICs

In an exclusive interview with BioPharma APAC, Ti Hwei How, Vice President of International Oncology & Market Access at AstraZeneca, sh...

December 02, 2024 | Interview

Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial

In an exclusive conversation with BioPharma APAC, Stefan Scheidl, VP and Global Head of Ophthalmology Medical Affairs at Roche, delves into the g...

December 02, 2024 | Interview

IPO Renaissance: Biopharma's Strategic Momentum Sets the Stage for 2025

The IPO class of 2024 has redefined the biopharma and life sciences landscape, marking a return to growth after a prolonged period of market caution. These...

November 27, 2024 | Report

Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility

In an exclusive interview with BioPharma APAC, Pam Cheng, Executive Vice President of Global Operations & IT and Chief Sustainability Officer at AstraZ...

November 15, 2024 | Interview

Thermo Fisher’s $22M OSD Investment: Shervin Hebbi on Accelerating Drug Development with Cutting-Edge Technology

In an exclusive Q&A with BioPharma APAC, Shervin Hebbi, Vice President of Oral Solid Dose (OSD) – North America at Thermo Fisher ...

November 01, 2024 | Interview

Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals

As JLABS Singapore marks its first anniversary, Alessandro Falcone, Head of JLABS Singapore, speaks with BioPharma APAC about the incubator’s rapid s...

October 30, 2024 | News

Why Singapore is the World’s New Pharma Powerhouse: Unpacking the Secrets Behind Its Manufacturing Boom

Singapore’s pharmaceutical revolution: How data and digital transformation are fueling a global hub Once primarily recognized for it...

October 22, 2024 | Opinion | By Venkatesh Arunachalam, General Manager of the Life Science Manufacturing group at Cognizant

Sanyou Bio CEO Lang Guojun Introduces World’s Largest Super-Trillion Molecule Library

In an interview with Tongxieyi, Sanyou Bio’s CEO Lang Guojun proudly announced the launch of the world’s largest super-trillion molecule librar...

October 21, 2024 | Interview

Breaking Down Portal Fatigue in Cell and Gene Therapy: Insights from TrakCel’s Experts

In this exclusive BioPharma APAC Q&A, Dr. Matthew Lakelin, Co-Founder and Head of Consultancy Services at TrakCel, and Antonios Spanos, Industry Adviso...

October 17, 2024 | Interview

Stay Connected